Table 5.
The relationship between NLR, LMR and 90-day mortality.
| Variables | Unadjusted | Adjusted | ||
|---|---|---|---|---|
| OR (95%CI) | p Value | OR (95%CI) | p Value | |
| WBC | 1.083 (1.033–1.136) | 0.001 | 1.084 (1.026–1.146) | 0.004 |
| ALC | 0.555 (0.359–0.858) | 0.008 | 0.635 (0.411–0.981) | 0.041 |
| ANC | 1.099 (1.045–1.155) | <0.001 | 1.096 (1.033–1.162) | 0.002 |
| AMC | 0.919 (0.671–1.259) | 0.601 | 1.083 (0.746–1.572) | 0.676 |
| NLR | 1.074 (1.046–1.102) | <0.001 | 1.061 (1.030–1.094) | <0.001 |
| LMR | 0.758 (0.648–0.886) | 0.001 | 0.765 (0.641–0.912) | 0.003 |
Adjusted by age, sex, initial GCS, systolic and diastolic BP, systolic and diastolic BP variability, BP lowering strategy, types of BP-lowering agents, unhealthy lifestyle including smoking and drinking, baseline ICH volume, time from stroke onset to blood sample, presence of intraventricular hemorrhage, hematoma location and hematoma expansion, presence of spot sign, presence of infection, and ND.